Download - Pi is 0091674907015898
-
ments with Dey Pharmaceutical, has received grant support from Merck and
Foodalle
rgy,anaphylaxis,
derm
atology,anddrugalle
rgySystem FEIA (Phadia, Uppsala, Sweden). The diagnosis of CMA was
made on the basis of a history of symptoms clearly associated with
exposure to milk, a positive oral food challenge, and/or a clear
improvement in eczema or other symptoms with milk avoidance.
IgE-mediated disease was defined as having a skin prick test with a
wheal diameter 3 mm and/or a cm-IgE 0.35 kU/L.The diagnosis of asthma, eczema, or allergic rhinitis was made by
the investigator. These data were collected on all patients from their
initial visit and then updated from their last visit available. Allergy to
Genentech, and is on the speakers bureau for Dey, Merck, and Glaxo. The
rest of the authors have declared that they have no conflict of interest.
Received for publication May 21, 2007; revised August 8, 2007; accepted for
publication August 8, 2007.
Available online October 12, 2007.
Reprint requests: Robert A. Wood, MD, CMSC 1102, Johns Hopkins Hospital,
600 North Wolfe St, Baltimore, MD 21287. E-mail: [email protected].
0091-6749/$32.00
2007 American Academy of Allergy, Asthma & Immunologydoi:10.1016/j.jaci.2007.08.023
1172The natural history omilk allergy
Justin M. Skripak, MD, Elizabeth C. Matsu
and Robert A. Wood, MD Baltimore, Md
Background: Cows milk allergy (CMA) is the most common
food allergy in infants and young children, affecting 2% to 3%
of the general population. Most studies have shown the
prognosis of developing tolerance to cows milk to be good, with
most outgrowing their allergy by age 3 years.
Objective: To define the natural course of CMA and identify
the factors that best predict outcome in a large referral
population of children with CMA.
Methods: Clinical history, test results, and final outcome were
collected on 807 patients with IgE-mediated CMA. Patients
were considered tolerant after they passed a challenge or
experienced no reactions in the past 12 months and had a cows
milk IgE (cm-IgE) level
-
J ALLERGY CLIN IMMUNOL
VOLUME 120, NUMBER 5
Skripak et al 1173
Foodallergy,anaphylaxis,
derm
atology,anddrugallergyother foods was defined as having had a clear symptomatic reaction to
the food and/or having had a positive SPT or food-specific IgE level.
The primary outcome of interest was acquisition of oral tolerance.
Oral milk challenges were routinely performed when, in the judgment
of the principal investigator, the patient had at least a 50% chance of
passing the challenge.9 Patients who were not likely to have acquired
tolerance, on the basis of either a history of recent reactions or
elevated cm-IgE levels, typically did not undergo oral challenges,
but continued to be followed.
For this study, several definitions of oral tolerance were used to
estimate a range of incidence rates for oral tolerance. The definitions
of oral tolerance were based on criteria that ranged from most
stringent to least stringent (Table I). During analysis of the data, each
definition was applied to the entire population. Under the most strin-
gent set of criteria (criteria 1), only patients who passed a formal milk
challenge or successfully introduced milk or concentrated milk pro-
ducts at home were considered tolerant. All other patients were con-
sidered to have persistent milk allergy. To take into account the fact
that some patients who had not undergone a milk challenge at home
or in the clinic could have acquired tolerance, a second definition
(criteria 2) of tolerance was also used. Under this second definition,
patients who had a cm-IgE level
-
J ALLERGY CLIN IMMUNOL
NOVEMBER 2007
1174 Skripak et al
Foodalle
rgy,anaphylaxis,
derm
atology,anddrugalle
rgyseven percent of clinic challenges were passed, and 24%of home challenges were passed. Three sets of criteriawere created to define the acquisition of milk tolerance.Each set of criteria was applied separately to the entirepopulation (n 5 807). When tolerance was defined usingthe most stringent criteria, as passing a milk challenge, wefound that only 5% outgrew their allergy by age 4 years,21% by age 8 years, 37% by age 12 years, and 55% by age16 years. When tolerance was defined as passing achallenge or a cm-IgE
-
J ALLERGY CLIN IMMUNOL
VOLUME 120, NUMBER 5
Skripak et al 1175
Foodallergy,anaphylaxis,
derm
atology,anddrugallergymodel, peak cm-IgE was stratified into 3 categories (20 kU/L), and each step upin peak cm-IgE category was associated with a 68%reduction in the likelihood of acquiring oral tolerance(hazard ratio [95% CI], 0.32 [.27-.38]).
DISCUSSION
In this referral population of children with milk allergy,the prognosis for developing tolerance is worse thanpreviously estimated. Using 3 sets of increasingly broadcriteria to define tolerance, incidence rates of tolerance at 4years ranged from
-
en
J ALLERGY CLIN IMMUNOL
NOVEMBER 2007
1176 Skripak et al
Foodalle
rgy,anaphylaxis,
derm
atology,anddrugalle
rgydeveloping tolerance. We realize that peak cm-IgE can bean impractical measure because it cannot be applied withthe same confidence to younger children. However, highercm-IgE levels were associated with poorer prognosis atall ages and, even in younger children, the peak cm-IgEcategories can be applied as a best case scenario incounseling families about prognosis. These data are inagreement with several previous studies that support thisassociation between increasing cm-IgE level and worseprognosis.4,5,10,11
The presence of both asthma and allergic rhinitis werealso associated with a lower likelihood of developingtolerance. These factors remained significant even in themultivariate analysis when controlling for peak cm-IgE
level. In previous studies, markers of atopy or IgE-mediated diseasefor example, the presence of urticariaor IgE-sensitization to certain foods such as egghavebeen associated with worse prognosis.6 However, it is im-portant to note that asthma and rhinitis may appear to beassociated with a poorer prognosis because children whoare followed longer are more likely to carry these diagno-ses as well as more likely to have retained milk allergy.
FIG 3. Relationship of peak cm-IgE level to resolution of IgE-
mediated CMA over the period of the first 18 years of life. Patients
were stratified by peak cm-IgE level, and survival curves for each
stratum of peak cm-IgE level were plotted. The number of patients
in each stratum was as follows:
-
In this population, the presence of other food allergies wasalso associated with a worse prognosis, although thisassociation was not statistically significant. In addition,a worse prognosis was observed among patients whohad ever received formula. However, this associationmay be biased because these data were missing for 20%of the population, and these findings should be confirmedin future studies.
In previous studies, rates of development of tolerancefor IgE-mediated or immediate-onsettype allergy havevaried: 76% by age 3 years,4 74% by age 5 years,6 and22% by age 18 months to 13 years.5 The wide differencesin these rates are likely related most to the population stud-ied, with the study by Host and Halken4 including an un-
significantly worse than what has been previously re-ported. Sensitivity persists into school age and beyond inthe majority of our patients. cm-IgE is highly predictive ofoutcome and should be used in counseling patients onprognosis. Prospective studies are needed to confirm thispotential increasing persistence of CMA.
We thank Elizabeth Johnson, MS, for her review of the statistical
analyses.
REFERENCES
1. Bock SA. Prospective appraisal of complaints of adverse reactions to
foods in children during the first 3 years of life. Pediatrics 1987;79:683-8.
2. Saarinen KM, Juntunen-Backman K, Jarvenpaa AL, Kuitunen P, Lope L,
J ALLERGY CLIN IMMUNOL
VOLUME 120, NUMBER 5
Skripak et al 1177
Foodallergy,anaphylaxis,
derm
atology,anddrugallergyselected group of children with milk allergy, and the studyby Hill et al5 focusing on a referral population more sim-ilar to ours. Most previous studies did not report details oncm-IgE levels, but from the information available, itappears that our population has higher levels on average,with peak cm-IgE levels exceeding 2 kU/L in 80% ofthe population, and exceeding 50 kU/L in 30%. Othermarkers of the high degree of atopy in our population in-clude 91% having at least 1 other food allergy, 49% withasthma, 40% with allergic rhinitis, and 71% with eczema,although these rates of asthma, eczema, and allergicrhinitis are consistent with those found in previousstudies.6,10,12
Although the poor prognosis demonstrated in this studymay be a result of this highly atopic referral population, itmay also be that the character of CMA has changed overtime, and that CMA may now truly be a more persistentdisease. In fact, many of the previous studies in this areaare now nearly 2 decades old. In our clinic population, wecontinue to see an increasing number of children whosemilk allergy persists into school age and even intoadolescence. We speculate that the factors driving therising prevalence of food allergy and other atopic condi-tions may also be contributing to the changing character ofCMA, and potentially other food allergies.
In conclusion, we have found in the largest cohort ofchildren with milk allergy ever reported that the prognosisfor the resolution of IgE-mediated CMA appearsRenlund M, et al. Supplementary feeding in maternity hospitals and the
risk of cows milk allergy: a prospective study of 6209 infants. J Allergy
Clin Immunol 1999;104:457-61.
3. Schrander JJ, van den Bogart JP, Forget PP, Schrander-Stumpel CT,
Kuijten RH, Kester AD. Cows milk protein intolerance in infants under
1 year of age: a prospective epidemiological study. Eur J Pediatr 1993;
152:640-4.
4. Host A, Halken S. A prospective study of cow milk allergy in Danish
infants during the first 3 years of life: clinical course in relation to clinical
and immunological type of hypersensitivity reaction. Allergy 1990;45:
587-96.
5. Hill DJ, Firer MA, Ball G, Hosking CS. Natural history of cows milk
allergy in children: immunological outcome over 2 years. Clin Exp Al-
lergy 1993;23:124-31.
6. Saarinen KM, Pelkonen AS, Makela MJ, Savilahti E. Clinical course and
prognosis of cows milk allergy are dependent on milk-specific IgE sta-
tus. J Allergy Clin Immunol 2005;116:869-75.
7. Bishop JM, Hill DJ, Hosking CS. Natural history of cow milk allergy:
clinical outcome. J Pediatr 1990;116:862-7.
8. Hill DJ, Davidson GP, Cameron DJ, Barnes GL. The spectrum of cows
milk allergy in childhood. Clinical, gastroenterological and immunologi-
cal studies. Acta Paediatr Scand 1979;68:847-52.
9. Perry TT, Matsui EC, Kay Conover-Walker M, Wood RA. The relation-
ship of allergen-specific IgE levels and oral food challenge outcome.
J Allergy Clin Immunol 2004;114:144-9.
10. Sampson HA. Utility of food-specific IgE concentrations in predicting
symptomatic food allergy. J Allergy Clin Immunol 2001;107:891-6.
11. Shek LP, Soderstrom L, Ahlstedt S, Beyer K, Sampson HA. Determina-
tion of food specific IgE levels over time can predict the development of
tolerance in cows milk and hens egg allergy. J Allergy Clin Immunol
2004;114:387-91.
12. Vanto T, Helppila S, Juntunen-Backman K, Kalimo K, Klemola T, Korpela
R, et al. Prediction of the development of tolerance to milk in children with
cows milk hypersensitivity. J Pediatr 2004;144:218-22.
The natural history of IgE-mediated cows milk allergyMethodsStatistical analysis
ResultsStudy populationCMA resolutionPredictors of prognosis
DiscussionReferences